Codes / ICD10CM / T50.A23

T50.A23 Poisoning by mixed bacterial vaccines without a pertussis component, assault

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by mixed bacterial vaccines without a pertussis component, assault

Summary

This condition describes poisoning resulting from exposure to mixed bacterial vaccines that do not contain a pertussis component, where the exposure is due to assault. The clinical presentation and management depend on the specific bacterial antigens involved, the nature of the assault, and the individual's immune response. Assault-related poisoning may involve intentional administration or exposure by another party.

Causes

Assault-related poisoning occurs when an individual is deliberately exposed to mixed bacterial vaccines without a pertussis component by another person. This may involve forced administration, injection, or other forms of exposure. The mixed bacterial vaccine components (excluding pertussis) are the primary agents involved in the toxic or adverse reaction.

Risk Factors

  • History of assault or violence
  • Access to vaccine products by the perpetrator
  • Underlying vulnerability (e.g., inability to consent or defend oneself)
  • Prior adverse reactions to bacterial vaccine components
  • Situations involving conflict or coercion

Symptoms

  • Localized reactions at the injection site (e.g., swelling, redness, pain)
  • Systemic symptoms such as fever, malaise, or irritability
  • Rare severe reactions like allergic responses or respiratory distress
  • Psychological distress related to the assault

Diagnosis

Diagnosis is based on a history of assault, clinical evaluation of symptoms, and confirmation of exposure to mixed bacterial vaccines without a pertussis component. Laboratory tests may assess for vaccine-related toxicity or allergic reactions. Documentation of the assault and associated circumstances is critical for accurate diagnosis.

Treatment Options

Treatment focuses on managing symptoms, addressing the toxic effects of the vaccine, and providing supportive care. This may include antihistamines for allergic reactions, analgesics for pain, and monitoring for systemic complications. Psychological support and safety measures are also important considerations.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning, the specific vaccine components, and the individual's overall health. Most cases resolve with appropriate treatment, but severe reactions may require extended monitoring. Follow-up care should address both physical recovery and any psychological impact of the assault.

Complications

  • Severe allergic reactions (e.g., anaphylaxis)
  • Infection at the injection site
  • Long-term psychological effects from the assault
  • Rare systemic toxicity from vaccine components

Lifestyle & Prevention

  • Avoid situations where assault is a risk
  • Ensure safe storage and handling of vaccine products
  • Seek support from healthcare providers or mental health professionals if at risk of assault
  • Follow recommended vaccination protocols to reduce unnecessary exposure

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur after suspected assault, especially if there are signs of severe allergic reactions, difficulty breathing, or significant pain. Report the assault to appropriate authorities and seek psychological support.

Tips for Medical Coders

Document the assault-related nature of the poisoning clearly, including details of the exposure and any associated injuries. Ensure the code T50.A23 is used when the poisoning is specifically due to assault involving mixed bacterial vaccines without a pertussis component. Verify that the absence of a pertussis component is confirmed in the medical record.

Book a walkthrough

T50.A23 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.